Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,581 | -81,172 | -58,032 | -84,686 | -26,511 |
| Depreciation Amortization | 1,783 | 3,550 | 2,366 | 2,775 | 1,146 |
| Accounts receivable | -1,696 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,341 | 3,100 | 1,755 | -2,292 | 4,287 |
| Other Working Capital | 13,591 | 4,283 | -633 | -17,327 | -30,240 |
| Other Operating Activity | 11,170 | 2,956 | 899 | 25,471 | 6,130 |
| Operating Cash Flow | $-60,074 | $-67,283 | $-53,645 | $-76,059 | $-45,188 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 40,900 | 19,000 | 16,272 | N/A | N/A |
| PPE Investments | -17,902 | -7,836 | -5,136 | -2,914 | -6,671 |
| Purchase Of Investment | -146,345 | N/A | N/A | -92,445 | -26,345 |
| Sale Of Investment | N/A | N/A | N/A | 29,233 | 43,418 |
| Other Investing Activity | 0 | 0 | -76 | 0 | 0 |
| Investing Cash Flow | $-123,347 | $11,164 | $11,060 | $-66,126 | $10,402 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 15,000 |
| Common Stock Issued | 1,970 | 117,952 | 62 | 1,358 | 1,545 |
| Other Financing Activity | 67,385 | 69,809 | -44 | 0 | 40,143 |
| Financing Cash Flow | $69,355 | $187,761 | $18 | $1,358 | $56,688 |
| Exchange Rate Effect | -4 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 173,119 | 41,477 | 84,044 | 222,161 | 200,259 |
| End Cash Position | 59,049 | 173,119 | 41,477 | 81,334 | 222,161 |
| Net Cash Flow | $-114,070 | $131,642 | $-42,567 | $-140,827 | $21,902 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,074 | -67,283 | -53,645 | -76,059 | -45,188 |
| Capital Expenditure | -17,902 | -7,836 | -5,136 | -2,914 | -6,671 |
| Free Cash Flow | -77,976 | -75,119 | -58,781 | -78,973 | -51,859 |